Following Recent FDA Advisory Discussions, PepMD Reaffirms Commitment to Clinical Standards and Research
As healthcare continues to evolve alongside advances in this area of healthcare, conversations increasingly extend beyond individual therapies to the systems that support their safe, responsible, and evidence-based use. For PepMD, a private standards body developing the credentialing and trust infrastructure for this area of healthcare, recent discussions during the U.S. Food and Drug Administration’s Pharmacy Compounding Advisory Committee (PCAC) meeting reinforced a mission the organization has pursued since its inception.
Founded by clinician Karthik Achari, PepMD has focused on strengthening the professional infrastructure surrounding this area of healthcare through clinician credentialing, pharmacy recognition, and research site authorization. Rather than responding to a single regulatory event, the organization says the FDA advisory discussions highlighted the continued need for educational standards, quality recognition, and structured evidence development as this area of healthcare continues to evolve.
On July 23, 2026, Achari delivered public comment during the Open Public Hearing portion of the FDA's Pharmacy Compounding Advisory Committee meeting at the agency's White Oak campus. His remarks did not advocate for or against any specific peptide or regulatory outcome. Instead, he addressed the professional infrastructure surrounding this area of healthcare, including how clinicians are evaluated, how pharmacy quality is verified, and how real-world clinical experience becomes structured evidence. The remarks are part of the public meeting record.
“The discussion reinforced what we’ve believed from the beginning,” said Achari. “As this area of healthcare grows, it needs standards, education, and accountability that help practitioners and patients make informed decisions.”
PepMD says healthcare fields typically mature through more than regulation alone. Professional standards, continuing education, verification systems, and evidence generation all play important roles in supporting responsible clinical practice alongside existing regulatory oversight.
That philosophy has guided the organization since its founding.
Rather than developing isolated programs, PepMD has built an integrated standards framework consisting of three connected initiatives: clinician credentialing, pharmacy recognition, and research site authorization. Together, the organization believes these initiatives create a comprehensive trust infrastructure designed specifically for this area of healthcare.
According to PepMD, clinician credentialing is intended to promote competency, continuing education, and responsible clinical decision-making. Pharmacy recognition is designed to identify organizations that meet defined quality expectations, creating greater transparency while complementing existing regulatory requirements. Research site authorization seeks to encourage standardized documentation and evidence development that can help strengthen future clinical understanding.
The organization believes these three functions work together to establish greater consistency across this area of healthcare while supporting practitioners, researchers, pharmacies, and ultimately patients.
Throughout the FDA advisory discussions, recurring themes included accountability, quality, evidence, provider responsibility, and patient safety. While viewpoints differed regarding individual regulatory questions, Achari observed a consistent emphasis on the importance of education, verification, and reliable information.
“People naturally focus on innovation first,” Achari said. “We believe the systems supporting that innovation deserve the same level of attention. Strong standards help responsible clinical practice develop over time.”
PepMD also believes clinician education will continue to become increasingly important as healthcare professionals evaluate emerging peptides, evolving research, and changing clinical information. The organization says structured credentialing programs can help establish consistent educational expectations while providing clinicians with additional resources as the field continues to mature.
Likewise, pharmacy recognition is intended to strengthen transparency and patient confidence by identifying organizations that demonstrate defined quality expectations. Rather than replacing regulatory oversight, PepMD views these efforts as complementary measures that encourage best practices throughout the broader healthcare ecosystem.
Research infrastructure represents the organization’s third long-term priority. PepMD believes significant clinical knowledge is generated every day through patient care, yet much of that information is never organized into structured evidence capable of informing future research. Through its research site authorization initiative, the organization aims to encourage standardized approaches to documentation and evidence development that complement traditional clinical research.
PepMD says these initiatives reflect its broader mission of strengthening trust throughout this area of healthcare. Operating as a non-commercial standards body, the organization believes professional standards and regulatory oversight serve distinct but complementary roles in advancing healthcare quality.
The organization’s guiding principle, “The Standard for Clinical Excellence,” reflects that long-term commitment to building trusted infrastructure that supports clinicians, researchers, pharmacies, and patients alike.
Looking ahead, PepMD plans to continue collaborating with healthcare professionals, researchers, and organizations committed to strengthening education, accountability, and evidence development across this area of healthcare. While regulatory discussions will continue to evolve, the organization says its mission remains focused on building lasting infrastructure that supports responsible clinical practice.
“Innovation will continue moving quickly,” Achari said. “Our focus is helping build the standards and trust that allow this area of healthcare to grow responsibly. That work doesn’t change based on any single meeting.”
About PepMD
PepMD is a private standards body developing the credentialing and trust infrastructure for this area of healthcare. Through clinician credentialing, pharmacy recognition, and research site authorization, the organization works to strengthen education, accountability, transparency, and evidence development across the evolving field of this area of healthcare. Guided by its mission, “The Standard for Clinical Excellence,” PepMD seeks to support responsible clinical practice through non-commercial professional standards.
Website: https://pepmd.com/
Karthik Achari
PepMD
karthik@pepmd.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
